| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.19 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |